Jove
Visualize
Contact Us

Related Experiment Videos

Hepatitis C and the correctional population.

R W Reindollar1

  • 1Center for Liver Diseases, Carolinas Medical Center, Charlotte, North Carolina 28207, USA.

The American Journal of Medicine
|February 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.

Alimentary pharmacology & therapeutics·2008
Same author

Viral hepatitis: practical approach.

Comprehensive therapy·1982
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hepatitis C virus (HCV) infection is highly prevalent in US correctional facilities, with many inmates infected before incarceration. Inconsistent identification and treatment hinder HCV control efforts within this population.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • The hepatitis C virus (HCV) epidemic significantly impacts the US correctional population, with 30-40% of inmates infected.
  • Injection drug use is the primary driver of HCV infection, both before and during incarceration.
  • Correctional facilities present high-risk environments for HCV transmission due to continued drug use and sexual activity.

Purpose of the Study:

  • To summarize the prevalence, transmission dynamics, and challenges of hepatitis C virus (HCV) infection in the US correctional system.
  • To highlight the need for improved HCV prevention and treatment strategies within correctional facilities.

Main Methods:

  • Review of epidemiologic data on HCV prevalence in US inmates.
  • Analysis of HCV transmission factors within correctional settings.

Related Experiment Videos

  • Identification of barriers to HCV control and prevention in correctional populations.

    • Main Results:

    • An estimated 30-40% of US inmates are infected with HCV, predominantly acquired pre-incarceration.
    • While seroconversion rates in prison are low (1.1 per 100 person-years), high inmate turnover facilitates community spread.
    • HCV identification and treatment are inconsistent due to limited resources, funding, and follow-up care.

    Conclusions:

    • Effective HCV control in correctional settings requires enhanced knowledge, education, policies, and treatment protocols.
    • Addressing inconsistent identification and treatment is crucial for preventing HCV spread.
    • Improved post-release follow-up care is essential for long-term HCV management.